Company Filing History:
Years Active: 2006-2009
Title: The Innovations of Désiré J Collen
Introduction
Désiré J Collen is a notable inventor based in London, GB, recognized for his significant contributions to the field of medical diagnostics. He holds three patents that showcase his innovative approach to detecting and determining the stages of coronary artery disease. His work has the potential to greatly enhance patient care and outcomes.
Latest Patents
Collen's latest patent focuses on a method for detecting the presence of coronary artery disease in patients from the general population. This method provides a clinically sufficient degree of diagnostic accuracy for distinguishing between various stages of the disease. The stages identified include the non-acute stage, which encompasses asymptomatic coronary artery disease or stable angina, and two acute stages known as unstable angina and acute myocardial infarction. The method relies on the clinically significant presence of specific markers in patient samples, including OxLDL, MDA-modified LDL, and troponin. These markers can be detected using monoclonal antibodies in undiluted human plasma at very low concentrations, demonstrating the precision of Collen's innovative approach.
Career Highlights
Throughout his career, Collen has worked with esteemed organizations such as Leuven Research & Development and the D. Collen Research Foundation. His experience in these institutions has allowed him to further his research and development efforts in the medical field.
Collaborations
Some of Collen's notable collaborators include Paul N Holvoet and Peter Carmeliet. Their combined expertise has contributed to advancements in medical diagnostics and research.
Conclusion
Désiré J Collen's innovative work in the detection of coronary artery disease exemplifies the impact of research and invention in healthcare. His patents not only reflect his dedication to improving diagnostic methods but also highlight the importance of collaboration in advancing medical science.